1,3,3-Trimethyl-2-oxabicyclo[2.2.2]oct-5-ene
Common Name: |
1,3,3-Trimethyl-2-oxabicyclo[2.2.2]oct-5-ene |
IUPAC Name: |
1,3,3-trimethyl-2-oxabicyclo[2.2.2]oct-5-ene |
Molecular Formula: |
C11H16O3 |
SMILES: |
CC1(C2CCC(O1)(C=C2)C)C |
Inchi: |
1S/C10H16O/c1-9(2)8-4-6-10(3,11-9)7-5-8/h4,6,8H,5,7H2,1-3H3 |
Inchi Key: |
LOOYOTLEOHYYOV-UHFFFAOYSA-N |
Cas No: |
92760-25-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
196.24 |
Mass (g/mol) |
152.12 |
Molar Refractivity |
56.03 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
4 |
Rings |
3 |
TPSA |
38.69 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
179.00 to 181.00 |
Vapor Pressure (mmHg@25.00 °C) |
1.238 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.45 |
LogP |
2.52 |
iLOGP |
2.62 |
XLOGP3 |
2.85 |
WLOGP |
2.36 |
MLOGP |
1.78 |
ESOL Log S |
-2.91 |
ESOL Solubility (mg/ml) |
0.244 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.32 |
Ali Solubility (mg/ml) |
0.09 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.28 |
Silicos-IT Solubility (mg/ml) |
0.1 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.47 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.829 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.698 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
1 |
OCT2 inhibitor |
0 |